Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

10514	Companies
221697	Keywords
150862	Articles
117245	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 09/16/2025 at 12:00, 8 months 18 days ago

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Moderna reports 8-fold increase in neutralizing antibodies with Spikevax 2025-2026 formula, reinforcing FDA approval. Clinical trial data supports efficacy against COVID-19 LP.8.1 variant

FDA Approval COVID-19 Vaccine Moderna Spikevax Neutralizing Antibodies
BRIEF

published on 09/02/2025 at 13:05, 9 months 2 days ago

Moderna to Present mRNA Therapeutics Data at 2025 ICIEM

MRNA Therapeutics Moderna Propionic Acidemia ICIEM Methylmalonic Acidemia
PRESS RELEASE

published on 09/02/2025 at 13:00, 9 months 2 days ago

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a

Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF

published on 08/27/2025 at 19:29, 9 months 7 days ago

Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA

FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
PRESS RELEASE

published on 08/27/2025 at 19:24, 9 months 7 days ago

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon

FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF

published on 08/22/2025 at 15:30, 9 months 12 days ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine

COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
PRESS RELEASE

published on 08/22/2025 at 15:25, 9 months 12 days ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted

COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing
BRIEF

published on 08/21/2025 at 13:05, 9 months 14 days ago

Moderna to Participate in Major September 2025 Conferences

Investor Conferences MRNA Medicine Moderna Live Webcast Healthcare Presentation
PRESS RELEASE

published on 08/21/2025 at 13:00, 9 months 14 days ago

Moderna to Present at Upcoming Conferences in September 2025
Moderna, Inc. to participate in upcoming investor conferences. The company's innovative mRNA technology redefines medicine creation, focusing on infectious diseases, oncology, and more

Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
BRIEF

published on 08/01/2025 at 13:05, 10 months 3 days ago

Moderna's Q2 2025 Financial Results and Business Updates

Cost Management FDA Approvals Q2 2025 Revenue Moderna Financial Results Vaccine Sales

Accesswire

Published on 06/04/2026 at 13:35, 20 minutes ago

Silver X Acquires 100% of Ccasahuasi: A Gold System Next Door to a Producing Mine, Defined with Only 903 Meters of Drilling and Open Along Strike and at Depth
Published on 06/04/2026 at 13:30, 25 minutes ago

Algo Grande Appoints Monica Ospina as ESG Advisor and Advances Digbee ESG Disclosure Submission
Published on 06/04/2026 at 13:00, 55 minutes ago

North Shore Begins Drilling at Rio Puerco
Published on 06/04/2026 at 12:30, 1 hour 25 minutes ago

Trans Canada Gold Nears Completion of Newly Installed Underground Electrical Facilities, and Drill Pad Set-ups and Prepares for Drilling at the Harrison Lake District Scale Gold Project
Published on 06/04/2026 at 09:01, 4 hours 54 minutes ago

Future Fuels Strengthens Drill Targets with 3D Gravity Inversion at the Hornby Basin; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 06/04/2026 at 13:35, 20 minutes ago

TCL Unveils Expanded Monitor Lineup in Europe, Including its First Flagship OLED+ Monitor
Published on 06/04/2026 at 13:15, 40 minutes ago

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
Published on 06/04/2026 at 13:00, 55 minutes ago

Haier Brings Youth Tennis and Fan Engagement to Roland-Garros 2026 with Clay Court Open and Fans Club Event
Published on 06/04/2026 at 13:00, 55 minutes ago

Dividend Declaration
Published on 06/04/2026 at 12:55, 1 hour ago

AGP & DTx Summit: Digital therapeutics show 0.54% HbA1c reduction as diabetes care moves from monitoring to change

Les Echos

Published on 06/04/2026 at 07:50, 6 hours 5 minutes ago

Schneider Electric launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2034 for a nominal amount of €800 million and a concurrent repurchase of its outstanding OCEANEs due 2030 by way of a re
Published on 06/03/2026 at 18:02, 19 hours 53 minutes ago

Information concerning the total number of voting rights and shares 2026 05 31
Published on 06/03/2026 at 17:45, 20 hours 10 minutes ago

Manitou Group signs an amendment to its Sustainability Linked Loan (SLL) credit agreement to align its ESG criteria with its LIFT strategy
Published on 06/03/2026 at 17:45, 20 hours 10 minutes ago

VOGO has won all lots in the National Rugby League’s latest call for tenders and has signed a strategic six-season partnership.
Published on 06/03/2026 at 17:45, 20 hours 10 minutes ago

Report on share repurchases from 27 May to 2 June 2026

View all LES ECHOS COMFI WIRE